Description
Irinotecan – Topoisomerase I Inhibitor for Colorectal and Lung Cancer
Irinotecan is a prescription chemotherapy drug that belongs to the class of topoisomerase I inhibitors. It is widely used in the treatment of metastatic colorectal cancer, small cell lung cancer (SCLC), and other solid tumors. Irinotecan works by inhibiting the enzyme topoisomerase I, which is essential for DNA replication, leading to DNA damage and cancer cell death.
At Oncomed Pharmacy, we provide authentic Irinotecan injections from trusted manufacturers, ensuring patients receive safe, effective, and high-quality oncology medicines.
________________________________________
Key Features of Irinotecan
- Indications:
o Metastatic colorectal cancer (first-line and second-line therapy)
o Small cell lung cancer (SCLC)
o Other off-label uses in solid tumors such as gastric, ovarian, and pancreatic cancers
- Formulation: Injectable solution for intravenous (IV) infusion.
- Mechanism of Action: Topoisomerase I inhibitor that prevents DNA unwinding, disrupting cancer cell replication.
- Patient Benefit: Proven survival benefit in colorectal cancer, often used in combination regimens such as FOLFIRI (with 5-FU and leucovorin).
________________________________________
Why Buy Irinotecan from Oncomed Pharmacy?
- 100% genuine and quality-assured chemotherapy medicines.
- Affordable pricing with reliable countrywide shipping.
- Cold-chain maintained packaging for potency and safety.
- Trusted oncology pharmacy specializing in colorectal cancer treatment medicines.
________________________________________
Uses of Irinotecan
- Standard treatment for metastatic colorectal cancer, often combined with 5-fluorouracil (5-FU) and leucovorin.
- Effective therapy for small cell lung cancer in combination regimens.
- Investigational and off-label use in gastric, ovarian, and pancreatic cancers.
Reviews
There are no reviews yet.